Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silva Markovic-Plese

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|March 20, 2009
Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosisSilva Markovic-Plese
Frontiers in Immunology|December 15, 2016
Activated IL-1RI Signaling Pathway Induces Th17 Cell Differentiation <i>via</i> Interferon Regulatory Factor 4 Signaling in Patients with Relapsing-Remitting Multiple SclerosisYonggang Sha, Silva Markovic-Plese
Self/Nonself|July 22, 2011
A role of IL-1R1 signaling in the differentiation of Th17 cells and the development of autoimmune diseasesYonggang Sha, Silva Markovic-Plese
Expert Review of Clinical Pharmacology|April 29, 2015
Immunomodulatory therapies for relapsing-remitting multiple sclerosis: monoclonal antibodies, currently approved and in testingJessica Craddock, Silva Markovic-Plese
Immunologic Research|May 20, 2008
Statins' immunomodulatory potential against Th17 cell-mediated autoimmune responseXin Zhang, Silva Markovic-Plese
Clinical Neurology and Neurosurgery|June 24, 2010
Interferon beta inhibits the Th17 cell-mediated autoimmune response in patients with relapsing-remitting multiple sclerosisXin Zhang, Silva Markovic-Plese
Endocrine, Metabolic & Immune Disorders Drug Targets|April 14, 2010
Interferon-beta inhibits Th17 cell differentiation in patients with multiple sclerosisVinod S Ramgolam, Silva Markovic-Plese
Journal of Signal Transduction|December 2, 2011
Regulation of suppressors of cytokine signaling as a therapeutic approach in autoimmune diseases, with an emphasis on multiple sclerosisVinod S Ramgolam, Silva Markovic-Plese
Clinical Neurology and Neurosurgery|June 5, 2004
The initiation of the autoimmune response in multiple sclerosisSilva Markovic-Plese, Clemencia Pinilla, Roland Martin
Journal of Neuroimmunology|September 10, 2016
Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS)Yazhong Tao, Xin Zhang, Silva Markovic-Plese
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|March 20, 2009
Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosisSilva Markovic-Plese
Frontiers in Immunology|December 15, 2016
Activated IL-1RI Signaling Pathway Induces Th17 Cell Differentiation <i>via</i> Interferon Regulatory Factor 4 Signaling in Patients with Relapsing-Remitting Multiple SclerosisYonggang Sha, Silva Markovic-Plese
Self/Nonself|July 22, 2011
A role of IL-1R1 signaling in the differentiation of Th17 cells and the development of autoimmune diseasesYonggang Sha, Silva Markovic-Plese
Expert Review of Clinical Pharmacology|April 29, 2015
Immunomodulatory therapies for relapsing-remitting multiple sclerosis: monoclonal antibodies, currently approved and in testingJessica Craddock, Silva Markovic-Plese
Immunologic Research|May 20, 2008
Statins' immunomodulatory potential against Th17 cell-mediated autoimmune responseXin Zhang, Silva Markovic-Plese
Clinical Neurology and Neurosurgery|June 24, 2010
Interferon beta inhibits the Th17 cell-mediated autoimmune response in patients with relapsing-remitting multiple sclerosisXin Zhang, Silva Markovic-Plese
Endocrine, Metabolic & Immune Disorders Drug Targets|April 14, 2010
Interferon-beta inhibits Th17 cell differentiation in patients with multiple sclerosisVinod S Ramgolam, Silva Markovic-Plese
Journal of Signal Transduction|December 2, 2011
Regulation of suppressors of cytokine signaling as a therapeutic approach in autoimmune diseases, with an emphasis on multiple sclerosisVinod S Ramgolam, Silva Markovic-Plese
Clinical Neurology and Neurosurgery|June 5, 2004
The initiation of the autoimmune response in multiple sclerosisSilva Markovic-Plese, Clemencia Pinilla, Roland Martin
Journal of Neuroimmunology|September 10, 2016
Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS)Yazhong Tao, Xin Zhang, Silva Markovic-Plese
Pageof 6